OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 22

Showing 22 citing articles:

Experimental Animal Models of Prodromal Parkinson’s Disease
Hodaka Yamakado, Ryōsuke Takahashi
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S369-S379
Open Access | Times Cited: 12

Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Kristina Lau, Rebecca Kotzur, Franziska Richter
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12

Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Timothy R. Sampson, Zachary D. Wallen, Woong-Jai Won, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
Thuy Thi Lai, Birthe Gericke, Malte Feja, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18

Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model
Cara Sophie Schreiber, Ivo Wiesweg, Stephanie Stanelle-Bertram, et al.
EBioMedicine (2024) Vol. 105, pp. 105191-105191
Open Access | Times Cited: 7

Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathy
Christopher Käufer, Miloš Stanojlović, Alina Schidlitzki, et al.
Journal of Parkinson s Disease (2025)
Open Access

Leveraging animal models to understand non-motor symptoms of Parkinson's disease
Thomas Wichmann, Alexandra Nelson, Eileen Ruth S. Torres, et al.
Neurobiology of Disease (2025), pp. 106848-106848
Open Access

Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson’s disease
Huixian Hong, Yong Wang, Marissa Menard, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3

Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3

Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61)
Kristina Lau, Lisa T. Porschen, Franziska Richter, et al.
Neurobiology of Disease (2023) Vol. 187, pp. 106298-106298
Open Access | Times Cited: 8

The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
Kelsey Bernard, J A Mota, Paige V Wene, et al.
Experimental Neurology (2024) Vol. 381, pp. 114926-114926
Open Access | Times Cited: 2

Double‐Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α‐Synuclein
Alina Schidlitzki, Miloš Stanojlović, Céline Fournier, et al.
Movement Disorders (2023) Vol. 38, Iss. 6, pp. 1044-1055
Open Access | Times Cited: 6

Cysteamine HCl Administration Impedes Motor and Olfactory Functions, Accompanied by a Reduced Number of Dopaminergic Neurons, in Experimental Mice: A Preclinical Mimetic Relevant to Parkinson’s Disease
Divya Bharathi Selvaraj, Anusiya Panneerselvam, Jemi Feiona Vergil Andrews, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 632-632
Open Access | Times Cited: 1

Olfactory deficit and gastrointestinal dysfunction precede motor abnormalities in alpha-Synuclein G51D knock-in mice
YoungDoo Kim, Joseph McInnes, Jiyoen Kim, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 1

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice
Lívia H. Morais, Joseph C. Boktor, Siamak MahmoudianDehkordi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 1

Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
Anna-Sophia Hartke, Cara Sophie Schreiber, Kristina Lau, et al.
Neurobiology of Disease (2024) Vol. 205, pp. 106773-106773
Open Access | Times Cited: 1

Suppression of the JAK/STAT Pathway Inhibits Neuroinflammation in the Line 61-PFF Mouse Model of Parkinson’s Disease
Huixian Hong, Yong Wang, Marissa Menard, et al.
Research Square (Research Square) (2024)
Open Access

The role of amphipathic and cationic helical peptides in Parkinson's disease
Carlos Pintado‐Grima, Salvador Ventura
Protein Science (2024) Vol. 34, Iss. 1
Open Access

A New Look at Animal Models of Neurological Disorders
Marie‐Françoise Chesselet
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 1-2
Open Access

Page 1

Scroll to top